Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
A little girl died in her sleep this morning just months after her family said that a "miracle" had saved her precious daughter from cancer.
The mother of Reeva Steenkamp, the model shot dead by Oscar Pistorius, has written about how she felt during the trial.
Customers could be losing out due to credit card companies not providing enough information, consumer group Which? has found.